Viwit

Viwit

You are here: HomeProductsLinagliptin

Contact us

  • Company Name: Viwit
  • Country/region: China
  • Contact Person: Mr.Keene Wei
  • Tel: 86-21-37775618
  • Email:

Linagliptin

  • CAS No:668270-12-0 8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-<br />methylquinazolin-2-yl)methyl]purine-2,6-dione
    Molecular Structure

    Detailed Description

    Linagliptin ( trade names Tradjenta and Trajenta,cas 668270-12-0) is a DPP-4 inhibitor developed by Boehringer Ingelheim for treatment of type II diabetes.Linagliptin (cas 668270-12-0) was approved by the U.S. Food and Drug Administration (FDA) on 2 May 2011 for treatment of type II diabetes. It is being marketed by Boehringer Ingelheim and Lilly.